showed a trendp = 0.052
Although no correlation was observed between the sCD163 levels and TNM stage in a Spearman’s rho correlation test ( p = 0.141), an intergroup analysis revealed that patients with TNM stage IV tumors showed a trend towards higher sCD163 levels compared to TNM stage 0/I patients ( p = 0.052, Figure 2 B).